Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

long-term condition

- PMLiVE

Pfizer faces opposition to AZ takeover as Q1 figures disappoint

Labour leader Ed Miliband calls for public inquiry into deal

- PMLiVE

Caroline Strachan leaves AstraZeneca

She will join American Express as VP, global business consulting for EMEA

- PMLiVE

Virgo Health adds to senior team

New and returning faces boost the agency’s offering

- PMLiVE

Kane & Finkel closes

Independent agency unable to survive loss of several key accounts

- PMLiVE

Ignore at your own risk

Information threats need to be addressed calmly and strategically

- PMLiVE

UPDATE: AZ rejects improved Pfizer bid

Continues to assert independence as Pfizer appeals to Prime Minister David Cameron

- PMLiVE

FDA approval for Nova’s leukaemia drug

Purixan expected to provide more accurate dosing for children

- PMLiVE

Novo Nordisk: Tresiba makes a solid start

Long-acting insulin capturing share of diabetes market

- PMLiVE

Bayer outlines some of its digital health needs

Wants to work with startups in areas such as oncology and men's health

- PMLiVE

Chiesi launches Flogoprofen website

Targets consumers and health professionals in Spain

- PMLiVE

Interview: Bruno Strigini, MSD

MSD’s president, Europe and Canada, on how pharma is adapting to the market’s new reality

- PMLiVE

Icon appoints Hugh Brady to board

He is former president of University College Dublin

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links